Taylor Wessing advised Healx on its funding round. Healx, an AI-enabled, clinical-stage biotech company specializing in rare diseases based in Cambridge UK, has raised $47 million...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised the investors on Mission Zero Technologies’ Series A funding. Climate tech leader Mission Zero Technologies secured £21.8 million in Series A funding. Investors...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Apollo Therapeutics on its series C funding round. Apollo Therapeutics Limited, a biopharmaceutical company headquartered in Cambridge, has successfully raised $226.5 million in...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Nuclera on the deal. Nuclera, the pioneer in making biology accessible to everyone through desktop bioprinting, raised an additional $15.5 million in Series...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised SDC Limited on the deal. SDC has signed an agreement with Azrieli Group owned, Norwegian-based operator, Green Mountain to acquire its London-based data...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Placid0 on the deal. Placid0 has been acquired by innovative eyecare brand, WALDO. Placid0 has created EASY, an eye assessment system mobile application,...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Nuclera on the deal. Nuclera, the pioneer in making biology accessible to everyone through desktop bioprinting, thorugh its Series B financing, raised a...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised the founders of Telensa Holdings Ltd on the deal. Telensa Holdings Ltd., a UK-based expert in wireless monitoring and control systems for smart...
You must be a Standard 1 Year member to access this content.
Taylor Wessing advised Cambridge Epigenetix on the deal. Temasek led the round with participation from new investors including Third Point and existing investors such as GV,...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised E Ink on the deal. Taylor Wessing advised Nuclera. E Ink, the leading innovator of electronic ink technology, announced the sale of its...
You must be a Standard 1 Year member to access this content.
